IGTP in 2025: 12 selected news stories
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
At the IGTP TODAY
News
Germans Trias Hospital launches the first screening program in Catalonia to detect type 1 diabetes before the onset of symptoms
Early diagnosis can help prevent serious complications, reduce hospital admissions and minimise the impact of disease onset in children and adolescents
_1766478647.jpeg)
A new study explores why the same mutation in the BRAF gene leads to different therapeutic responses to its inhibitors in melanoma and colorectal cancer
Researchers from the B·ARGO at IGTP and ICO have conducted a comparative analysis of the impact of BRAF gene mutations in melanoma and colorectal cancer, published in the journal BBA Reviews on Cancer.
IGTP secures over €13 million to support the development of research projects and strengthen research talent
The Germans Trias i Pujol Research Institute has secured €13,208,000 through several funding calls supporting research projects and research activity, the results of which were announced this December, including both Spanish and Catalan-level calls.
IGTP celebrates 30 years of transforming knowledge into health
On 11 December, IGTP celebrated its 30th anniversary with an institutional and Christmas event that brought together professionals from across the Institute in a space for recognition, remembrance, and looking ahead to the future.
The CARE Annual Meeting reviews the program’s cancer research activity and sets priorities for the months ahead
The III CARE Annual Meeting, held on 5 December at BCIN, brought together the cancer research community of the Can Ruti Campus for a day focused on scientific dialogue, interdisciplinarity and future strategy.
IGTP drives collaborative science in health after three years of cooperation in biotechnology
The closing event celebrated on 17 November highlighted the work carried out and strengthened the commitment to maintain and expand the synergies created within the framework of the Plan. IGTP has contributed to several collaborative projects, focused on type 2 diabetes, breast cancer and medical databases.
New study maps the landscape of KRAS mutations and targeted therapies in colorectal cancer
A team of researchers from IGTP and ICO has studied alterations in the KRAS gene in colorectal cancer by combining genomic analyses with a systematic review of targeted compounds and clinical trials. Their findings, published in the journal npj Precision Oncology, provide and updated overview to guide future advances in this cancer's treatment.
The Core Facilities of the Can Ruti Campus: cutting-edge technology driving excellence in research
At the Campus Can Ruti Core Facilities Infoday, the Josep Carreras Leukaemia Research Institute and the Germans Trias i Pujol Research Institute showcased their scientific services and the support they can offer to research conducted both on the campus and externally. The event also featured the presentation of the new IGTP-IJC Joint Flow Cytometry Unit, which has one of the most advanced infrastructures in the EU, as well as the new IJC's Translational-PATH2CURE hub, which aims to accelerate the translation of scientific discoveries into treatments for patients.
The Fundació Catalunya La Pedrera awards 33 Talents Grants to retain medical and research talent in Catalonia
The Talents Grants for the 2024 and 2025 editions have been granted by the Fundació Catalunya La Pedrera, supporting healthcare professionals in developing research projects that will lead to their doctoral theses. This initiative, originally created through a collaboration with the Research Institute and Hospital Germans Trias i Pujol, now also includes Hospital Clínic Barcelona, the Vall d'Hebron Institute of Oncology and Hospital de Bellvitge.
